An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol (FF/VI) 200/25 Microgram (mcg) , FF/VI 100/25 mcg, and FF 100 mcg in Adults and Adolescents With Persistent Asthma.
Clinical trial NCT01686633 · COMPLETED
Trial details
- NCT number
- NCT01686633
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-09-20
- Primary completion
- 2013-10-01
- Enrollment
- 1040
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.